JP2022522312A5 - - Google Patents

Info

Publication number
JP2022522312A5
JP2022522312A5 JP2021559054A JP2021559054A JP2022522312A5 JP 2022522312 A5 JP2022522312 A5 JP 2022522312A5 JP 2021559054 A JP2021559054 A JP 2021559054A JP 2021559054 A JP2021559054 A JP 2021559054A JP 2022522312 A5 JP2022522312 A5 JP 2022522312A5
Authority
JP
Japan
Application number
JP2021559054A
Other languages
Japanese (ja)
Other versions
JPWO2020205934A5 (https=
JP2022522312A (ja
JP7627008B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/026116 external-priority patent/WO2020205934A1/en
Publication of JP2022522312A publication Critical patent/JP2022522312A/ja
Publication of JPWO2020205934A5 publication Critical patent/JPWO2020205934A5/ja
Publication of JP2022522312A5 publication Critical patent/JP2022522312A5/ja
Priority to JP2024101773A priority Critical patent/JP7710215B2/ja
Application granted granted Critical
Publication of JP7627008B2 publication Critical patent/JP7627008B2/ja
Priority to JP2025110439A priority patent/JP7811768B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559054A 2019-04-03 2020-04-01 ピロール化合物 Active JP7627008B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024101773A JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物
JP2025110439A JP7811768B2 (ja) 2019-04-03 2025-06-30 ピロール化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962828919P 2019-04-03 2019-04-03
US62/828,919 2019-04-03
US201962932686P 2019-11-08 2019-11-08
US62/932,686 2019-11-08
PCT/US2020/026116 WO2020205934A1 (en) 2019-04-03 2020-04-01 Pyrrole compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024101773A Division JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物

Publications (4)

Publication Number Publication Date
JP2022522312A JP2022522312A (ja) 2022-04-15
JPWO2020205934A5 JPWO2020205934A5 (https=) 2023-04-11
JP2022522312A5 true JP2022522312A5 (https=) 2023-04-11
JP7627008B2 JP7627008B2 (ja) 2025-02-05

Family

ID=72667046

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021559054A Active JP7627008B2 (ja) 2019-04-03 2020-04-01 ピロール化合物
JP2024101773A Active JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物
JP2025110439A Active JP7811768B2 (ja) 2019-04-03 2025-06-30 ピロール化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024101773A Active JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物
JP2025110439A Active JP7811768B2 (ja) 2019-04-03 2025-06-30 ピロール化合物

Country Status (22)

Country Link
US (3) US11191747B2 (https=)
EP (2) EP4733305A2 (https=)
JP (3) JP7627008B2 (https=)
KR (2) KR20260036605A (https=)
CN (4) CN121108187A (https=)
AU (2) AU2020253444C1 (https=)
BR (1) BR112021019817A2 (https=)
CA (1) CA3134635A1 (https=)
CL (1) CL2021002575A1 (https=)
CO (1) CO2021014210A2 (https=)
DK (1) DK3947349T3 (https=)
FI (1) FI3947349T3 (https=)
GE (2) GEP20257772B (https=)
IL (1) IL286902B2 (https=)
MA (1) MA55564A (https=)
MX (1) MX2021012105A (https=)
PE (1) PE20220252A1 (https=)
PH (1) PH12021552513A1 (https=)
SG (1) SG11202110718PA (https=)
TW (1) TWI846853B (https=)
UA (1) UA129029C2 (https=)
WO (1) WO2020205934A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121108187A (zh) 2019-04-03 2025-12-12 阿里戈斯治疗公司 吡咯化合物
CN114685514A (zh) * 2020-12-29 2022-07-01 广东东阳光药业有限公司 新型酰胺吡咯类化合物及其在药物中的应用
WO2022156758A1 (zh) * 2021-01-22 2022-07-28 广东东阳光药业有限公司 新型酰胺吡咯类化合物及其在药物中的用途
CA3231695A1 (en) 2021-09-08 2023-03-16 Aligos Therapeutics, Inc. Modified short interfering nucleic acid (sina) molecules and uses thereof
CN118974014B (zh) * 2022-03-17 2026-01-27 成都微芯药业有限公司 吡咯酰胺类化合物及其制备方法和用途
CN116120219A (zh) * 2022-12-27 2023-05-16 吉斯凯(苏州)制药有限公司 一种多取代吡咯类化合物及其制备方法和在制备hbv衣壳蛋白抑制剂中的应用
JP2026503674A (ja) * 2023-01-26 2026-01-29 アリゴス セラピューティクス インコーポレイテッド B型肝炎併用療法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784782A (en) 1986-03-27 1988-11-15 The Lubrizol Corporation Heterocyclic compounds useful as additives for lubricant and fuel compositions
BR0112826A (pt) 2000-07-17 2003-06-24 Ranbaxy Lab Ltd Derivados da oxazolidinona como antimicrobianos
EP1389209B1 (en) 2001-04-24 2009-04-08 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
GB0119172D0 (en) 2001-08-06 2001-09-26 Melacure Therapeutics Ab Phenyl pyrrole derivatives
ZA200505523B (en) 2002-12-20 2006-09-27 Amgen Inc Asthma and allergic inflammation modulators
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
GB2398299A (en) 2003-02-13 2004-08-18 Melacure Therapeutics Ab Pharmaceutically active phenyl-pyrrole derivatives
US20070191336A1 (en) 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
AU2005221959C1 (en) 2004-03-13 2010-06-17 Kyoto University Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same
US20060102471A1 (en) 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer
US20060105355A1 (en) 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer having a linker moiety
US8835476B2 (en) 2005-03-04 2014-09-16 Fan Wu Synthesis of novel antimicrobials
US20100234379A1 (en) 2005-07-28 2010-09-16 Bahr Ben A Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity
US20070065877A1 (en) 2005-09-19 2007-03-22 Combimatrix Corporation Microarray having a base cleavable succinate linker
KR101507375B1 (ko) 2006-09-15 2015-04-07 엑스커버리 홀딩 컴퍼니 엘엘씨 키나아제 억제제 화합물
EP2155720B1 (en) 2007-06-08 2013-07-17 Advinus Therapeutics Private Limited Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
CN101679358B (zh) 2007-06-18 2013-10-30 塞诺菲-安万特股份有限公司 作为p2y12拮抗剂的吡咯衍生物
CA2754492A1 (en) 2009-03-05 2010-09-10 Purdue Research Foundation Method for early imaging of atherosclerosis
WO2010107736A2 (en) 2009-03-20 2010-09-23 University Of Virginia Patent Foundation Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
BR112012009576A2 (pt) 2009-10-22 2019-09-24 Univ Vanderbilt potencializador alostérico de mglur4, composições, e métodos de tratamento de disfunção neurológica
BR112012028894A2 (pt) 2010-05-12 2019-09-24 Univ Vanderbilt sulfona heterocíclica como potenciadores alostéricos de mglur4, composições e métodos de tratamento de disfunção neurológica
KR20130087495A (ko) 2010-06-15 2013-08-06 바이엘 인텔렉쳐 프로퍼티 게엠베하 안트라닐산 유도체
MX2013002895A (es) 2010-09-14 2013-06-05 Inst Biochemii I Biofizyki Pan Compuestos como moduladores de una proteina cftr mutante y su uso para tratar enfermedades asociadas con las deficiencias de la proteina cftr.
WO2012047525A2 (en) 2010-09-27 2012-04-12 Endocyte, Inc. Folate conjugates for treating inflammation of the eye
WO2012078902A2 (en) 2010-12-08 2012-06-14 Proteostasis Therapeutics, Inc. Proteostasis regulators
WO2012087976A2 (en) 2010-12-21 2012-06-28 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
WO2012154880A1 (en) 2011-05-09 2012-11-15 Proteostasis Therapeutics, Inc. Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
DK2707101T3 (da) 2011-05-12 2019-05-13 Proteostasis Therapeutics Inc Proteostaseregulatorer
EP3085368A1 (en) 2011-07-01 2016-10-26 Baruch S. Blumberg Institute Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
US8835640B1 (en) 2011-11-16 2014-09-16 Paresh T. Gandhi Nicotine derivatives
HK1210969A1 (en) 2012-01-20 2016-05-13 奥克塞拉有限公司 Substituted heterocyclic compounds for disease treatment
EP3345597A3 (en) 2012-09-19 2018-08-22 Faller & Williams Technology, LLC Pkc delta inhibitors for use as therapeutics
TWI651300B (zh) 2013-05-17 2019-02-21 健生科學愛爾蘭無限公司 胺磺醯基吡咯醯胺衍生物及其作為用於治療b型肝炎藥物的用途
DK3024819T3 (en) * 2013-07-25 2018-06-06 Janssen Sciences Ireland Uc GLYOXAMIDE-SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B
KR102290189B1 (ko) 2013-10-23 2021-08-17 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 카르복스아미드 유도체 및 b형 간염 치료용 의약으로서의 이의 용도
CN104672221B (zh) 2013-11-29 2018-01-23 中国科学院上海有机化学研究所 一种氟代苯并杂环‑杂芳环结构的合成方法
US10040780B2 (en) 2014-03-03 2018-08-07 The Regents Of The University Of California Mcl-1 antagonists
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US20160166679A1 (en) 2014-12-12 2016-06-16 Purdue Research Foundation Method of treatment using folate conjugates and tyrosine kinase inhibitors
KR101726059B1 (ko) 2015-07-28 2017-04-12 한양대학교 산학협력단 디피롤 유도체와 암모늄 염을 포함하는 브롬화수소 가스 검출용 조성물 및 이를 포함하는 브롬화수소 가스 검출용 색변환 센서
KR101726060B1 (ko) 2015-07-28 2017-04-12 한양대학교 산학협력단 디피롤 유도체와 금속 염을 포함하는 염화수소 가스 검출용 조성물 및 이를 포함하는 염화수소 가스 검출용 색변환 센서
WO2017081615A1 (en) 2015-11-09 2017-05-18 Wockhardt Limited 7-oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections
US10752584B2 (en) * 2016-03-09 2020-08-25 Emory University Elimination of hepatitis B virus with antiviral agents
JOP20190024A1 (ar) * 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
CN108250121A (zh) 2016-12-28 2018-07-06 上海长森药业有限公司 磺酰胺-芳基酰胺类化合物及其治疗乙型肝炎的药物用途
CN115974753A (zh) 2018-03-30 2023-04-18 正大天晴药业集团股份有限公司 含有n杂五元环化合物和用途
BR112021006403A2 (pt) 2018-10-05 2021-07-06 Univ Emory agentes monômeros e multiméricos anti-hbv
MX2021010145A (es) 2019-02-22 2021-09-14 Janssen Sciences Ireland Unlimited Co Derivados de amida utiles en el tratamiento de una infeccion por vhb o de enfermedades inducidas por vhb.
CN121108187A (zh) 2019-04-03 2025-12-12 阿里戈斯治疗公司 吡咯化合物
AU2020385034B2 (en) 2019-11-13 2024-11-14 Xi'an Xintong Pharmaceutical Research Co., Ltd. HBV inhibitor and use thereof
CN114685514A (zh) 2020-12-29 2022-07-01 广东东阳光药业有限公司 新型酰胺吡咯类化合物及其在药物中的应用

Similar Documents

Publication Publication Date Title
BR102020022457A2 (https=)
CN306068376S (https=)
CN305740340S (https=)
CN305541282S (https=)
CN305543710S (https=)
CN305544023S (https=)
CN305544725S (https=)
CN305546009S (https=)
CN305583226S (https=)
CN305589426S (https=)
CN305593432S (https=)
CN305626818S (https=)
CN305627427S (https=)
CN305630460S (https=)
CN305631309S (https=)
CN305635215S (https=)
CN305644016S (https=)
CN305645107S (https=)
CN305646899S (https=)
CN305649135S (https=)
CN305650692S (https=)
CN305689429S (https=)
CN305699535S (https=)
CN305723088S (https=)
CN305723923S (https=)